Literature DB >> 28914633

Gaps in Current Knowledge and Priorities for Future Research in Dry Eye.

Ian J Saldanha1, Kay Dickersin, Susan T Hutfless, Esen K Akpek.   

Abstract

PURPOSE: Dry eye, a common yet underrecognized and evolving field, has few recommended treatment algorithms, mostly based on expert consensus rather than robust research evidence. There are high costs associated with managing dry eye and conducting research to identify effective and safe long-term treatments. To support evidence-based management of dry eye, our purpose was to identify and prioritize important clinical research questions for future clinical research.
METHODS: We translated recommendations from the American Academy of Ophthalmology's 2013 Preferred Practice Patterns for dry eye into answerable clinical research questions about treatment effectiveness. Clinicians around the world who manage patients with dry eye rated each question's importance from 0 (not important) to 10 (very important) using a 2-round online Delphi survey. We considered questions as "important" if ≥75% of respondents assigned a rating of 6 or more in round 2. We mapped the identified important clinical research questions to reliable systematic reviews published up to March 2016.
RESULTS: Seventy-five clinicians from at least 21 countries completed both Delphi rounds. Among the 58 questions, 24 met our definition of "important": 9/24 and 7/24 addressed topical and systemic treatments, respectively. All 4 questions with the highest 25th percentiles addressed topical treatments. Although 6/24 "important" questions were associated with 4 existing reliable systematic reviews, none of these reviews came to a definitive conclusion about treatment effectiveness.
CONCLUSIONS: We identified gaps pertaining to treatment options for dry eye. Future clinical research on the management of dry eye should strongly consider these prioritized questions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28914633      PMCID: PMC5678755          DOI: 10.1097/ICO.0000000000001350

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  22 in total

1.  Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps.

Authors:  Jimmy T Le; Susan Hutfless; Tianjing Li; Neil M Bressler; James Heyward; Ava K Bittner; Adam Glassman; Kay Dickersin
Journal:  Ophthalmol Retina       Date:  2017 Mar-Apr

Review 2.  Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease.

Authors:  Marta Sacchetti; Flavio Mantelli; Alessandro Lambiase; Alessandra Mastropasqua; Daniela Merlo; Stefano Bonini
Journal:  Br J Ophthalmol       Date:  2013-12-16       Impact factor: 4.638

3.  Setting priorities for comparative effectiveness research on management of primary angle closure: a survey of Asia-Pacific clinicians.

Authors:  Tsung Yu; Tianjing Li; Kinbo J Lee; David S Friedman; Kay Dickersin; Milo A Puhan
Journal:  J Glaucoma       Date:  2015 Jun-Jul       Impact factor: 2.503

Review 4.  Efficacy of polyunsaturated fatty acids for dry eye syndrome: a meta-analysis of randomized controlled trials.

Authors:  Wei Zhu; Yan Wu; Guigang Li; Juan Wang; Xinyu Li
Journal:  Nutr Rev       Date:  2014-09-18       Impact factor: 7.110

5.  Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.

Authors:  Ashley Behrens; John J Doyle; Lee Stern; Roy S Chuck; Peter J McDonnell; Dimitri T Azar; Harminder S Dua; Milton Hom; Paul M Karpecki; Peter R Laibson; Michael A Lemp; David M Meisler; Juan Murube Del Castillo; Terrence P O'Brien; Stephen C Pflugfelder; Maurizio Rolando; Oliver D Schein; Berthold Seitz; Scheffer C Tseng; Gysbert van Setten; Steven E Wilson; Samuel C Yiu
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

6.  Setting priorities for comparative effectiveness research: a case study using primary open-angle glaucoma.

Authors:  Tianjing Li; Ann-Margret Ervin; Roberta Scherer; Henry Jampel; Kay Dickersin
Journal:  Ophthalmology       Date:  2010-08-30       Impact factor: 12.079

Review 7.  Treatment of primary Sjögren syndrome: a systematic review.

Authors:  Manuel Ramos-Casals; Athanasios G Tzioufas; John H Stone; Antoni Sisó; Xavier Bosch
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

8.  Identifying research priorities for health care priority setting: a collaborative effort between managers and researchers.

Authors:  Neale Smith; Craig Mitton; Stuart Peacock; Evelyn Cornelissen; Stuart MacLeod
Journal:  BMC Health Serv Res       Date:  2009-09-15       Impact factor: 2.655

9.  A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry.

Authors:  John P Whitcher; Caroline H Shiboski; Stephen C Shiboski; Ana Maria Heidenreich; Kazuko Kitagawa; Shunhua Zhang; Steffen Hamann; Genevieve Larkin; Nancy A McNamara; John S Greenspan; Troy E Daniels
Journal:  Am J Ophthalmol       Date:  2009-12-29       Impact factor: 5.258

10.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

View more
  7 in total

1.  Ocular Manifestations and Burden Related to Sjögren Syndrome: Results of a Patient Survey.

Authors:  Ian J Saldanha; Vatinee Y Bunya; Sara S McCoy; Matthew Makara; Alan N Baer; Esen K Akpek
Journal:  Am J Ophthalmol       Date:  2020-06-20       Impact factor: 5.258

2.  Research Questions and Outcomes Prioritized by Patients With Dry Eye.

Authors:  Ian J Saldanha; Rebecca Petris; Genie Han; Kay Dickersin; Esen K Akpek
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

3.  Evaluation of Clinical Questions and Patient-Important Outcomes Associated With the Treatment of Age-Related Macular Degeneration.

Authors:  Kristina B Lindsley; Susan Hutfless; Barbara S Hawkins; Jill F Blim; Dan Roberts; Timothy W Olsen; Flora Lum; Kay Dickersin
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

Review 4.  Cochrane Eyes and Vision: a perspective introducing Cochrane Corner in Eye.

Authors:  Jennifer Evans; Tianjing Li; Gianni Virgili; Richard Wormald
Journal:  Eye (Lond)       Date:  2019-02-19       Impact factor: 3.775

Review 5.  Topical corticosteroids for dry eye.

Authors:  Su-Hsun Liu; Ian J Saldanha; Alison G Abraham; Thanitsara Rittiphairoj; Scott Hauswirth; Darren Gregory; Cristos Ifantides; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2022-10-21

6.  Topical cyclosporine A therapy for dry eye syndrome.

Authors:  Cintia S de Paiva; Stephen C Pflugfelder; Sueko M Ng; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-09-13

Review 7.  False Myths versus Medical Facts: Ten Common Misconceptions Related to Dry Eye Disease.

Authors:  Giuseppe Giannaccare; Vincenzo Scorcia
Journal:  Biomedicines       Date:  2020-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.